MediciNova
MNOV
32 hedge funds and large institutions have $19M invested in MediciNova in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 12 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.01% less ownership
Funds ownership: 15.55% → 14.54% (-1%)
7% less capital invested
Capital invested by funds: $20.4M → $19M (-$1.39M)
24% less funds holding
Funds holding: 42 → 32 (-10)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Bailard
Foster City,
California
|
+$69.1K |
| 2 |
Barclays
London,
United Kingdom
|
+$28.9K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.4K |
| 4 |
State Street
Boston,
Massachusetts
|
+$23.1K |
| 5 |
Renaissance Technologies
New York
|
+$18.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$352K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$295K |
| 3 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$144K |
| 4 |
HF
HRT Financial
New York
|
-$115K |
| 5 |
Goldman Sachs
New York
|
-$90K |
MNOV Hedge Fund Activity: Q1 2022 in Review
32 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2022, worth a combined $19M — down 6.8% from $20.4M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of MNOV and 2 opened new positions — a net loss of 10 holders — while 12 trimmed existing stakes and 9 added.
The largest buyer was Bailard, opening a new position worth an estimated $69.1K. The largest seller was Anson Funds Management, exiting entirely with an estimated $352K sold.
- 32 institutional investors held MediciNova (MNOV) as of Q1 2022, down from 42 in Q4 2021.
- Funds reported $19M of MediciNova stock for Q1 2022, down 6.8% quarter-over-quarter.
- 2 funds opened new MediciNova positions in Q1 2022 and 12 closed out, a net change of -10 holders.
- The largest MediciNova buyer in Q1 2022 was Bailard, an estimated $69.1K added.
- The largest MediciNova seller in Q1 2022 was Anson Funds Management, an estimated $352K sold.
Based on aggregated 13F filings for Q1 2022.